Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Daiichi Sankyo
Elevation Oncology
Seagen Inc.
Universitair Ziekenhuis Brussel
OncoNano Medicine, Inc.
Seagen Inc.
Eli Lilly and Company
University of Alabama at Birmingham
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
POM Wonderful LLC
University of Florida